Delivery Order SPE2DB22D1106-SPE2DB24FFGN1

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,738.96 firm fixed-price delivery order is for the supply of Wegovy 1 mg/0.5 ml pens, with an ultimate completion date of October 18, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Wegovy 0.5 mg/0.5 ml pens. The $2,194.16 firm fixed-price delivery order has a completion date of June 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Wegovy 2.4 mg/0.75 ml pens. The contract has a ceiling value of $5,965.98 and is a Firm Fixed Price Delivery Order with a completion date of November 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of Wegovy 1.7 mg/0.75 ml pens. The contract is a $4,053.86 firm fixed-price delivery order with a completion date of May 3, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,026.75 firm fixed price contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens. The contract has a period of performance through November 21, 2024 and is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA valued at $999,999,999. The IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Wegovy 0.5 mg/0.5 ml pens. The contract has a firm fixed price of $23,742.24 and a ceiling value of the same amount. It is a delivery order contract with an ultimate completion date of August 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy, a 1 mg/0.5 ml drug pen. The $1,097.08 firm fixed price delivery order has an ultimate completion date of August 1, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Wegovy 1 mg/0.5 ml pens. The $6,072.59 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,499.68 firm-fixed-price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pens. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Wegovy 2.4 mg/0.75 ml pens. The contract has a ceiling value of $21,101.60 and runs through February 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFGN1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Wegovy 1 mg/0.5 ml pens. The contract, valued at $4,186.72, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a range of medical commodities, including pharmaceutical products, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/12/24, 9:03 AM